Rani Therapeutics Holdings (RANI) Other Working Capital Changes (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Other Working Capital Changes of -$477000.0 for Q1 2026, little changed year-over-year from -$476004.2 in Q1 2025, and up 1.24% quarter-over-quarter from -$483000.0 in Q4 2025.
Rani Therapeutics Holdings (RANI) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$477000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes changed 0.21% year-over-year to -$477000.0; the TTM figure through Mar 2026 stood at -$1.9 million (changed 0.0% YoY), while the FY2025 annual figure was -$1.9 million, down 5.59% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$477000.0, up from -$483000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $9.4 million in Q4 2025, with the low at -$1.7 million in Q1 2026.
- The 5-year median for Other Working Capital Changes is -$407500.0 (2023), against an average of $338312.5.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes soared 62.21% in 2024, then tumbled 380.81% in 2025.
- Rani Therapeutics Holdings' Other Working Capital Changes stood at $528000.0 in 2022, then gained by 1.33% to $535000.0 in 2023, then sank by 188.97% to -$476000.0 in 2024, then retreated by 1.47% to -$483000.0 in 2025, then increased by 1.24% to -$477000.0 in 2026.
- Business Quant data shows RANI's Other Working Capital Changes at -$477000.0 in Q1 2026, -$483000.0 in Q4 2025, and -$472000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Rani Therapeutics Holdings | 163.98 Mn | 163.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -477,000.00 |
| Jun 30, 2026 | -477,000.00 |
| Jun 30, 2026 | -477,000.00 |
| Mar 31, 2026 | -477,000.00 |
| Mar 31, 2026 | -477,000.00 |
| Mar 31, 2026 | -477,000.00 |
| Dec 31, 2025 | -483,000.00 |
| Dec 31, 2025 | -483,000.00 |
| Dec 31, 2025 | -483,000.00 |
| Sep 30, 2025 | -472,000.00 |
| Sep 30, 2025 | -472,000.00 |
| Sep 30, 2025 | -472,000.00 |
| Jun 30, 2025 | -476,000.00 |
| Jun 30, 2025 | -476,000.00 |
| Jun 30, 2025 | -476,000.00 |
| Mar 31, 2025 | -478,000.00 |
| Mar 31, 2025 | -478,000.00 |
| Mar 31, 2025 | -478,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |